Tema Oncology ETF Rating $41.15 -0.15 (-0.36%) As of 07/24/2026 03:59 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Oncology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.CANC Aggregate RatingModerate Buy 2.71Holdings in CANC have an aggregate rating of Moderate Buy based on 382 analyst ratings issued in the past year covering 22 companies (66.2% of the portfolio).CANC Aggregate Price Target$41.15High Prediction$41.15Average Prediction$41.15Low Prediction$41.15Holdings in CANC have an aggregate price target of $41.15 and a range of $41.15 to $41.15 covering 22 companies (66.2% of the portfolio).CANC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Oncology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 CANC Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.87%RVMDRevolution Medicines$189.23+0.3%1.8298 of 5 stars2.95$144.67 -23.5%22News CoveragePositive NewsAnalyst Forecast5.01%LLYEli Lilly and Company$1,196.18+0.9%3.7482 of 5 stars2.87$1,283.64 7.3%31Trending News4.89%COGTCogent Biosciences$39.76-1.2%1.7986 of 5 stars2.85$45.90 15.4%13News CoveragePositive News3.86%RHHBYRoche$54.70+1.4%2.4709 of 5 stars2.27$51.50 -5.9%11News Coverage3.58%MRKMerck & Co., Inc.$131.06+0.4%4.5328 of 5 stars2.70$133.94 2.2%20Trending NewsOptions Volume3.46%BMYBristol Myers Squibb$62.05+0.9%4.0593 of 5 stars2.37$61.25 -1.3%19Trending NewsUpcoming Earnings3.36%ABBVAbbVie$259.10+0.8%4.3526 of 5 stars2.84$268.10 3.5%25Trending NewsUpcoming EarningsAnalyst Forecast3.29%JNJJohnson & Johnson$263.43+1.6%4.2872 of 5 stars2.80$265.30 0.7%25Trending News3.18%IMNMImmunome$22.21+0.9%3.2486 of 5 stars2.86$33.17 49.3%14News CoverageAnalyst Forecast2.86%EXELExelixis$55.37-0.5%2.8766 of 5 stars2.40$49.00 -11.5%20News CoveragePositive NewsAnalyst Forecast2.69%GMABGenmab A/S$28.87-1.0%4.7923 of 5 stars2.77$39.28 36.1%13Analyst Upgrade2.66%AMGNAmgen$376.04+1.2%4.0371 of 5 stars2.43$356.62 -5.2%30Positive News2.65%LEGNLegend Biotech$22.22-5.6%2.927 of 5 stars2.50$55.38 149.3%14Analyst DowngradeGap Down2.59%IDYAIDEAYA Biosciences$35.40-2.3%3.8552 of 5 stars2.81$50.25 41.9%16Positive News2.53%CGONCG Oncology$69.32-2.5%3.3518 of 5 stars2.71$81.73 17.9%14Positive News2.48%BBIOBridgeBio Pharma$84.02+1.3%2.9786 of 5 stars2.83$95.21 13.3%23Positive News2.25%ONCBeOne Medicines$325.90-0.3%4.2689 of 5 stars2.80$394.00 20.9%15Trending NewsAnalyst Forecast1.91%CELCCelcuity$82.62-6.5%3.1709 of 5 stars2.83$155.18 87.8%121.84%ERASErasca$19.11-1.2%1.9679 of 5 stars2.64$21.64 13.2%11Trending News1.82%RLAYRelay Therapeutics$18.44-3.4%2.9573 of 5 stars2.86$24.92 35.1%14News CoverageAnalyst Forecast1.74%HALOHalozyme Therapeutics$81.93+1.3%3.1515 of 5 stars2.54$81.60 -0.4%13News CoverageAnalyst Forecast1.69%ZLABZai Lab$19.22-2.3%2.9328 of 5 stars2.71$40.00 108.1%7 This page (NASDAQ:CANC) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CANC Stock Alerts